Literature DB >> 9261279

Relationship of LDL size to insulin sensitivity in normoglycemic men.

L Mykkänen1, S M Haffner, D L Rainwater, P Karhapää, H Miettinen, M Laakso.   

Abstract

A preponderance of small, dense LDL has been suggested to be more atherogenic than larger, more buoyant LDL. Although several studies have suggested associations of small, dense LDL with hyperinsulinemia, few data are available on the relation of small, dense LDL to insulin resistance. We examined the association of LDL particle size determined by gradient gel electrophoresis with the rates of whole-body glucose uptake (WBGU) as determined by the hyperinsulinemic euglycemic clamp with indirect calorimetry in 87 Finnish normoglycemic men. LDL size was significantly positively correlated with the rates of WBGU (overall, r = .31, P < .01; oxidative, r = .23, P < .05; and nonoxidative, r = .31, P < .01). Rates of WBGU were also significantly lower in subjects with small LDL particles (< or = 26.0 nm) compared with those in subjects with larger LDL particles (> 26.0 nm). This relation was not explained by obesity. Serum triglyceride concentrations were found to significantly affect the relationship of LDL particle size to WBGU. Specifically, LDL size was correlated with the rates of WBGU in men with mildly elevated triglyceride levels but not in men with low triglyceride levels. Serum VLDL triglyceride concentration was a substantially stronger determinant of LDL size than were the rates of WBGU. WBGU was not significantly related to LDL size when adjusted for triglycerides. We conclude that a preponderance of small, dense LDL particles is associated with insulin resistance and that serum triglyceride concentration modifies this relationship.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261279     DOI: 10.1161/01.atv.17.7.1447

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.

Authors:  Hideo Makimura; Meghan N Feldpausch; Takara L Stanley; Noelle Sun; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

2.  A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

3.  Genetics of non-conventional lipoprotein fractions.

Authors:  Alexis C Frazier-Wood
Journal:  Curr Genet Med Rep       Date:  2015-08-29

4.  Sex-specific associations between screen time and lipoprotein subfractions.

Authors:  Alexis C Frazier-Wood; Ingrid B Borecki; Mary F Feitosa; Paul N Hopkins; Caren E Smith; Donna K Arnett
Journal:  Int J Sport Nutr Exerc Metab       Date:  2013-08-26       Impact factor: 4.599

5.  Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study.

Authors:  Angela A Rivellese; Lidia Patti; David Kaufman; Jianhui Zhu; Giovanni Annuzzi; Olga Vaccaro; Sven O Ebbesson; Wm James Howard; Gabriele Riccardi; Barbara V Howard
Journal:  Atherosclerosis       Date:  2008-04-18       Impact factor: 5.162

6.  A clustering analysis of lipoprotein diameters in the metabolic syndrome.

Authors:  Alexis C Frazier-Wood; Stephen Glasser; W Timothy Garvey; Edmond K Kabagambe; Ingrid B Borecki; Hemant K Tiwari; Michael Y Tsai; Paul N Hopkins; Jose M Ordovas; Donna K Arnett
Journal:  Lipids Health Dis       Date:  2011-12-19       Impact factor: 3.876

7.  Genetic risk scores associated with baseline lipoprotein subfraction concentrations do not associate with their responses to fenofibrate.

Authors:  Alexis C Frazier-Wood; Mary K Wojczynski; Ingrid B Borecki; Paul N Hopkins; Chao-Qiang Lai; Jose M Ordovas; Robert J Straka; Micheal Y Tsai; Hemant K Tiwari; Donna K Arnett
Journal:  Biology (Basel)       Date:  2014-08-25

Review 8.  Secretory Phospholipase A2s in Insulin Resistance and Metabolism.

Authors:  Michael S Kuefner
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.